Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region Implications for a high-rate seropositive region

Main Article Content

Subash Chirkut *
(*) Corresponding Author:
Subash Chirkut | chirkut@ukzn.ac.za

Abstract

Sub-Saharan Africa is the region in the world with the most people infected with the human immunodeficiency virus (HIV). The incidence of breast cancer is also rising in the region. This transcript focusses on the burden of these two diseases when they converge in the same populace. This comprehensive literature review of the topic suggests a trend towards an increasing incidence of breast cancer in the HIV-infected population, and the rationale for such a tendency is hypothesized, especially in the context of the availability of highly active antiretroviral therapy. Besides the age at diagnosis, all other clinical characteristics appear to be similar in HIV-positive and HIV-negative breast cancer populations. Outcomes of the different treatment modalities for breast cancer in HIV-positive patients are also appraised and finally innovative areas of future research are suggested along with plausible recommendations.


Downloads month by month

Downloads

Download data is not yet available.

Article Details